IRIS
Di Lorenzo, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.518
NA - Nord America 2.543
SA - Sud America 1.458
EU - Europa 401
AF - Africa 226
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.153
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.303
SG - Singapore 1.368
BR - Brasile 1.043
CN - Cina 658
HK - Hong Kong 537
VN - Vietnam 236
MX - Messico 152
IT - Italia 130
IN - India 129
AR - Argentina 123
BD - Bangladesh 88
IQ - Iraq 76
EC - Ecuador 70
TR - Turchia 66
CO - Colombia 63
ID - Indonesia 62
VE - Venezuela 55
SA - Arabia Saudita 47
ZA - Sudafrica 47
GB - Regno Unito 43
PK - Pakistan 40
RU - Federazione Russa 38
MA - Marocco 37
PH - Filippine 37
CA - Canada 36
PY - Paraguay 31
TN - Tunisia 30
DE - Germania 29
CL - Cile 28
UA - Ucraina 27
UZ - Uzbekistan 27
MY - Malesia 26
FR - Francia 25
NL - Olanda 24
EG - Egitto 23
KE - Kenya 21
ES - Italia 18
BO - Bolivia 16
AE - Emirati Arabi Uniti 15
ET - Etiopia 15
JO - Giordania 14
LB - Libano 13
PE - Perù 13
UY - Uruguay 13
DZ - Algeria 12
OM - Oman 11
NP - Nepal 9
AL - Albania 8
AZ - Azerbaigian 8
CR - Costa Rica 8
JM - Giamaica 8
KG - Kirghizistan 8
LY - Libia 7
RS - Serbia 7
TH - Thailandia 7
KZ - Kazakistan 6
PS - Palestinian Territory 6
PT - Portogallo 6
BY - Bielorussia 5
CH - Svizzera 5
DO - Repubblica Dominicana 5
GE - Georgia 5
PA - Panama 5
SN - Senegal 5
TT - Trinidad e Tobago 5
AO - Angola 4
AU - Australia 4
BH - Bahrain 4
CM - Camerun 4
HN - Honduras 4
HU - Ungheria 4
NG - Nigeria 4
RO - Romania 4
BB - Barbados 3
CZ - Repubblica Ceca 3
GR - Grecia 3
IL - Israele 3
NI - Nicaragua 3
PL - Polonia 3
AT - Austria 2
BE - Belgio 2
BS - Bahamas 2
CI - Costa d'Avorio 2
FI - Finlandia 2
GT - Guatemala 2
HT - Haiti 2
LI - Liechtenstein 2
ML - Mali 2
SC - Seychelles 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BZ - Belize 1
CD - Congo 1
CG - Congo 1
CV - Capo Verde 1
CY - Cipro 1
Totale 8.121
Salva come PNG Salva come JPEG
Città #
San Jose 1.593
Singapore 798
Hong Kong 515
Ashburn 344
Beijing 316
Mexico City 121
Ho Chi Minh City 96
São Paulo 73
Hanoi 51
Rio de Janeiro 31
Rome 31
Baghdad 30
Santa Clara 30
Tashkent 25
Quito 23
Belo Horizonte 22
Brasília 22
Lahore 22
Caracas 20
Haiphong 18
Jeddah 18
Naples 18
Nairobi 17
Istanbul 16
Johannesburg 16
Santiago 16
Campinas 15
Curitiba 15
Guayaquil 15
Medellín 15
Salvador 14
Addis Ababa 13
Amman 13
Chicago 13
Dhaka 13
Asunción 12
Buenos Aires 12
Kuala Lumpur 12
New York 12
Montevideo 11
Riyadh 11
Bogotá 10
Cape Town 10
Casablanca 10
Dammam 10
Jakarta 10
London 10
Milan 10
Porto Alegre 10
Santo André 10
Cairo 9
Erbil 9
Goiânia 9
Muscat 9
Sorocaba 9
Tunis 9
Hyderabad 8
La Paz 8
New Delhi 8
Ribeirão Preto 8
San José 8
Uberlândia 8
Baku 7
Boardman 7
Delhi 7
Fortaleza 7
João Pessoa 7
Lima 7
Manaus 7
Cali 6
Contagem 6
Córdoba 6
Guarulhos 6
Joinville 6
Karbala 6
Maringá 6
Mauá 6
Mumbai 6
Rabat 6
São Bernardo do Campo 6
Tirana 6
Adana 5
Agadir 5
Barquisimeto 5
Belford Roxo 5
Belém 5
Biên Hòa 5
Cleveland 5
Cuenca 5
Da Nang 5
Dubai 5
Fes 5
Itanhaém 5
Itaquaquecetuba 5
Kathmandu 5
Las Vegas 5
Machala 5
Malang 5
Manila 5
Maracaibo 5
Totale 4.886
Salva come PNG Salva come JPEG
Nome #
The use of tamsulosin in the medical treatment of ureteral calculi: Where do we stand? 73
Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patients 64
A case of renal melanoma metastasis: Description of clinico-pathological features 45
Clinical characteristics of metastatic prostate cancer patients infected with COVID-19 in South Italy 39
Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma 38
Development and Validation of the PREVESMED Questionnaire: A Comprehensive Tool for Assessing Adherence to a Mediterranean Lifestyle 37
Prostate Cancer Detection in the "Grey Area" of Prostate-Specific Antigen Below 10 ng/ml: Head-to-Head Comparison of the Updated PCPT Calculator and Chun's Nomogram, Two Risk Estimators Incorporating Prostate Cancer Antigen 3 36
Management of AIDS-related Kaposi's sarcoma 36
The Impact of Routine Molecular Screening for SARS-CoV-2 in Patients Receiving Anticancer Therapy: An Interim Analysis of the Observational COICA Study 34
Medical expulsive treatment of distal-ureteral stones using tamsulosin: A single-center experience 34
Thalidomide in combination with oral daily cyclophosphamide in patients with pretreated hormone refractory prostate cancer: A phase I clinical trial 33
Validation of Psychometric Tools for Assessing Fatigue, Mood, and Sleep Quality: Application in the PREVES-STOP Study. 33
The evolving systemic treatment landscape for patients with advanced prostate cancer 33
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 32
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 32
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 32
Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) Significantly Improve Prostate Cancer Detection at Initial Biopsy in a Total PSA Range of 2-10 ng/ml 32
Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy 32
Paclitaxel in Pretreated Metastatic Penile Cancer: Final Results of a Phase 2 Study 32
Words of Wisdom. Re: Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy 32
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis 31
It is no longer the time to disregard thyroid metastases from breast cancer: a case report and review of the literature 31
Predictors of Residual T1 High Grade on Re- Transurethral Resection in a Large Multi-Institutional Cohort of Patients with Primary T1 High-Grade/Grade 3 Bladder Cancer 31
Adrenalectomy: defining its role in the surgical treatment of renal cell carcinoma. 31
Gemcitabine Versus Bacille Calmette-Guerin After Initial Bacille Calmette-Guerin Failure in Non-Muscle-Invasive Bladder Cancer A Multicenter Prospective Randomized Trial 31
Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysis 31
A Prognostic Model for Patients With Metastatic Renal Cell Cancer: What's New? 31
Synergistic Combination of Quercetin and Mafosfamide in the Treatment of Bladder Cancer Cells 31
Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers 31
Neuroendocrine immunophenotype as predictor of clinical recurrence in 110 patients with prostate cancer 31
Contralateral prophylactic mastectomy in male breast cancer: Where do we stand 31
Imatinib mesylate in thymic epithelial malignancies 30
Instant messaging in cancer care 30
Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: A phase II study 30
Impact of Dietary Supplements on Clinical Outcomes and 2 Quality of Life in Patients with Breast Cancer: A Systematic Review 30
READY: Real-world data from an Italian compassionate use program of avelumab first-line maintenance (1LM) treatment for locally advanced or metastatic urothelial carcinoma (la/mUC) 30
A comprehensive outlook on intracerebral therapy of malignant gliomas. 30
A Retrospective Study of Cemiplimab Effectiveness in Elderly Patients with Squamous Cell Carcinoma of the Skin: Insights from a Real-Life Scenario 30
Phase II trial of gemcitabine, prednisone, and zoledronic acid in pretreated patients with hormone refractory prostate cancer 29
Immunotherapy for the treatment of prostate cancer 29
Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detection 29
The use of interferon in melanoma patients: a systematic review 29
Soluble interleukin-6 receptor to interleukin-6 (sIL-6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy 29
Expression of HECA-452 in parapsoriasis and mycosis fungoides 29
Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patients 29
Predictors of Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis 29
Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer - A multi-institutional, long-term experience 29
Testicular cancer from diagnosis to epigenetic factors 28
Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients 28
Numerical study of laminar confined impinging slot jets with nanofluids 28
Impact of previous nephrectomy on clinical outcome of metastatic renal carcinoma treated with immune-oncology (I-O). A real-world study on behalf of Meet-URO group (MeetUro-7b) 28
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings 28
PSA declines and survival in patients with metastatic castration-resistant prostate cancer treated with enzalutamide: A retrospective case-report study 28
New perspectives in the therapy of castration resistant prostate cancer 28
Optimal management of a patient with recurrent nasopharyngeal carcinoma 28
Outcomes associated with first-line PD-1 and PD-L1 inhibitors vs. sunitinib in patients with renal cell cancer with sarcomatoid features: a systematic review and meta-analysis 28
A Challenging Surgical Approach to Locally Advanced Primary Urethral Carcinoma: A Case Report and Literature Review 28
Dynamic sentinel node biopsy in clinically node-negative penile cancer versus radical inguinal lymphadenectomy: a comparative study 28
Adrenal sparing surgery in the treatment of renal cell carcinoma: when is it possible? 28
Chirurgia conservativa e qualità di vita in pazienti con carcinoma renale localizzato. 28
INCREASED EXPRESSION OF THE AUTOCRINE MOTILITY FACTOR IS ASSOCIATED WITH POOR PROGNOSIS IN PATIENTS WITH CLEAR CELL – RENAL CELL CARCINOMA 28
Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: A retrospective Italian survey 28
Predicting early and delayed bleedings in children who undergo adeno-tonsillectomy surgery. Is it really possible? 28
KIDNEY CANCER Overall survival is an unsuitable primary end point 28
Sipuleucel-T (Provenge®) for castration-resistant prostate cancer 28
An adjusted indirect comparison of everolimus and sorafenib therapy in sunitinib-refractory metastatic renal cell carcinoma patients using repeated matched samples 28
Kaempferol, myricetin and fisetin in prostate and bladder cancer: a systematic review of literature 28
Effect of baseline characteristics on cabazitaxel treatment duration in patients with metastatic castration-resistant prostate cancer (mCRPC): a post hoc analysis of the compassionate use (CUP)/expanded access programs (EAP) and CAPRISTANA registry 28
Activity of platinum-based chemotherapy in advanced prostate cancer patients with and without DNA repair gene aberrations: An International Collaborative Analysis 28
Vesicourethral anastomosis during radical retropubic prostatectomy: Does the number of sutures matter? 27
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: a systematic review and meta-analysis 27
Activity and safety of pegylated liposomal doxorubicin as first-line therapy in the treatment of non-visceral classic Kaposi's sarcoma: A multicenter study 27
Involvement of growth factor receptors of the epidermal growth factor receptor (EGFR) family in prostate cancer development and in the progression to androgen- independence. 27
Involvement of growth factor receptors of the epidermal growth factor receptor family in prostate cancer development and progression to androgen independence 27
Real-world experience with cabazitaxel in patients with metastatic castration-resistant prostate cancer: a final, pooled analysis of the compassionate use programme and early access programme 27
Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer 27
Toxicities of Targeted Therapy and Their Management in Kidney Cancer 27
Thermal and fluid dynamic behaviors of confined laminar impinging slot jets with nanofluids 27
Metastatic Renal Cell Carcinoma: Recent Advances in the Targeted Therapy Era 27
Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis 27
Computed-Tomography-Structured Reporting in Middle Ear Opacification: Surgical Results and Clinical Considerations From a Large Retrospective Analysis 27
Evaluation of Directed Graph-Mapping in Complex Atrial Tachycardias 27
Is gemcitabine an option in BCG-refractory nonmuscle-invasive bladder cancer? A single-arm prospective trial 27
Focus on localized laryngeal amyloidosis: Management of five cases 27
Expression of epidermal growth factor ( EGFR) correlates with disease relapse and progression to androgen –independence in human prostate cancer. 27
Combination therapy for metastatic renal cell carcinoma 27
A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma 27
Dysregulated metabolism: A relevant player in prostate cancer progression and clinical management 27
Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma 27
Intralabyrinthine Schwannoma of the Intravestibular Subtype: A Difficult Diagnosis 26
Docetaxel Rechallenge in Castration-Resistant Prostate Cancer: Scientific Legitimacy of Common Clinical Practice 26
Real-world cabazitaxel safety: the Italian Early-Access Programme in metastatic castrate-resistant prostate cancer 26
Predictors of outcomes with EGFR mutated non small cell lung cancer receiving EGFR tyrosine kinases inhibitors: a systemic review and meta-analysis 26
Penile cancer: current therapy and future directions 26
Incidence of fatigue and low dose of corticosteroids in patients receiving systemic treatment: a metanalysis of randomized trials 26
Re: Matthew R. Smith, Maha Hussain, Fred Saad, et al. Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer. N Engl J Med. 2022;386:1132–1142 26
New Agents for Prostate Cancer. 26
Docetaxel Rechallenge in a Heavily Pretreated Patient with Castration-Resistant Prostate Cancer 26
Laminar confined impinging slot jets with nanofluids on isothermal surfaces 26
Complete response as an intermediate end point in patients receiving salvage systemic therapy for urothelial carcinoma 26
Totale 3.013
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.463
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.463
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20252.165 0 0 0 28 338 19 114 372 101 60 553 580
2025/20266.357 266 27 355 434 922 444 687 408 2.064 750 0 0
Totale 8.522